Nueclear Web Banner
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
E-JCRT CORRESPONDENCE
Year : 2015  |  Volume : 11  |  Issue : 3  |  Page : 646

Safety of rituximab in a patient with chronic renal failure and low-grade non-Hodgkin lymphoma


1 Department of Hematology - Oncology, Hotel Dieu de France University Hospital, Saint Joseph University, Beirut, Lebanon
2 Department of Histology Pathology, Hotel Dieu de France University Hospital, Saint Joseph University, Beirut, Lebanon

Correspondence Address:
Joseph Kattan
Adib Ishac St., Sahnaoui Bld, sixth floor, Beirut
Lebanon
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0973-1482.148677

Rights and Permissions

An 82-year-old man, with known chronic renal failure and a creatinine clearance (CrCl) of 18 mL/min, was diagnosed with low-grade marginal zone non-Hodgkinlymphoma (NHL) of his right orbit. He received rituximab as single treatment (375 mg/m 2 every 3 weeks). After eight cycles, almost complete response was obtained, rituximab was extremely well-tolerated, and his creatinine levels remained stable throughout the whole treatment.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1853    
    Printed25    
    Emailed1    
    PDF Downloaded100    
    Comments [Add]    

Recommend this journal